Physician profile
Benjamin Yu
NPI 1629596226
$5,381.23
in general payments reported to CMS, 2019-2025
7 companies · $2,451 in 2025
The $2,451 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $963 · 2024: $1,968 · 2025: $2,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,467 · Travel and Lodging: $1,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,466.92 |
| Travel and Lodging | $1,914.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,357.45 | 2023-2025 | Lumenis Pulse 120h, Ams 700, Rezum Generator |
| Coloplast Corp | $496.39 | 2023-2025 | Titan |
| Ethicon US, LLC | $222.55 | 2025 | Dermabond Prineo, Vistaseal, Stratafix |
| Endo Pharmaceuticals INC. | $130.38 | 2023 | Xiaflex |
| Integra Lifesciences Corporation | $80.15 | 2023-2025 | Medihoney, Biodoptix, Biodfactor |
| Astellas Pharma US INC | $61.02 | 2023 | Xtandi |
| Fujifilm Healthcare Americas Corporation | $33.29 | 2023-2025 | Arietta Precision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.